Bayer’s (BAYRY) Chronic Cough Candidate Meets Efficacy Goal Posted byZacks Equity Research September 7, 2021 Leave a comment on Bayer’s (BAYRY) Chronic Cough Candidate Meets Efficacy Goal Bayer (BAYRY) posts positive data from the phase IIb PAGANINI study which is evaluating its investigational candidate, eliapixant, in patients with re…